Perakizumab (INN) is a humanized monoclonal antibody designed for the treatment of arthritis.Statement On A Nonproprietary Name Adopted By The USAN Council - Perakizumab, American Medical Association. It binds to IL17A and acts as an immunomodulator.
This drug was developed by Genentech/Roche.
References